256 related articles for article (PubMed ID: 35797441)
1. Risk factors for breast cancer-related lymphedema in patients undergoing 3 years of prospective surveillance with intervention.
Koelmeyer LA; Gaitatzis K; Dietrich MS; Shah CS; Boyages J; McLaughlin SA; Taback B; Stolldorf DP; Elder E; Hughes TM; French JR; Ngui N; Hsu JM; Moore A; Ridner SH
Cancer; 2022 Sep; 128(18):3408-3415. PubMed ID: 35797441
[TBL] [Abstract][Full Text] [Related]
2. Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema.
Kaufman DI; Shah C; Vicini FA; Rizzi M
Breast Cancer Res Treat; 2017 Dec; 166(3):809-815. PubMed ID: 28831632
[TBL] [Abstract][Full Text] [Related]
3. A Comparison of Bioimpedance Spectroscopy or Tape Measure Triggered Compression Intervention in Chronic Breast Cancer Lymphedema Prevention.
Ridner SH; Dietrich MS; Boyages J; Koelmeyer L; Elder E; Hughes TM; French J; Ngui N; Hsu J; Abramson VG; Moore A; Shah C
Lymphat Res Biol; 2022 Dec; 20(6):618-628. PubMed ID: 35099283
[No Abstract] [Full Text] [Related]
4. Correlation of Bioimpedance Spectroscopy with Risk Factors for the Development of Breast Cancer-Related Lymphedema.
Vicini F; Shah C; Whitworth P; Walker M; Shi J
Lymphat Res Biol; 2018 Dec; 16(6):533-537. PubMed ID: 30133336
[No Abstract] [Full Text] [Related]
5. The Risk of Subclinical Breast Cancer-Related Lymphedema by the Extent of Axillary Surgery and Regional Node Irradiation: A Randomized Controlled Trial.
Boyages J; Vicini FA; Shah C; Koelmeyer LA; Nelms JA; Ridner SH
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(4):987-997. PubMed ID: 33127493
[TBL] [Abstract][Full Text] [Related]
6. Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions.
Kilgore LJ; Korentager SS; Hangge AN; Amin AL; Balanoff CR; Larson KE; Mitchell MP; Chen JG; Burgen E; Khan QJ; O'Dea AP; Nye L; Sharma P; Wagner JL
Ann Surg Oncol; 2018 Oct; 25(10):2948-2952. PubMed ID: 29987599
[TBL] [Abstract][Full Text] [Related]
7. Axillary Treatment and Chronic Breast Cancer-Related Lymphedema: Implications for Prospective Surveillance and Intervention From a Randomized Controlled Trial.
Boyages J; Vicini FA; Manavi BA; Gaw RL; Koelmeyer LA; Ridner SH; Shah C
JCO Oncol Pract; 2023 Dec; 19(12):1116-1124. PubMed ID: 37816208
[TBL] [Abstract][Full Text] [Related]
8. Reducing chronic breast cancer-related lymphedema utilizing a program of prospective surveillance with bioimpedance spectroscopy.
Whitworth PW; Cooper A
Breast J; 2018 Jan; 24(1):62-65. PubMed ID: 29063664
[TBL] [Abstract][Full Text] [Related]
9. Bioimpedance spectroscopy for breast cancer-related lymphedema assessment: clinical practice guidelines.
Shah C; Whitworth P; Valente S; Schwarz GS; Kruse M; Kohli M; Brownson K; Lawson L; Dupree B; Vicini FA
Breast Cancer Res Treat; 2023 Feb; 198(1):1-9. PubMed ID: 36566297
[TBL] [Abstract][Full Text] [Related]
10. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study.
Soran A; Ozmen T; McGuire KP; Diego EJ; McAuliffe PF; Bonaventura M; Ahrendt GM; DeGore L; Johnson R
Lymphat Res Biol; 2014 Dec; 12(4):289-94. PubMed ID: 25495384
[TBL] [Abstract][Full Text] [Related]
11. A Lymphedema Surveillance Program for Breast Cancer Patients Reveals the Promise of Surgical Prevention.
Hahamoff M; Gupta N; Munoz D; Lee BT; Clevenger P; Shaw C; Spiguel L; Singhal D
J Surg Res; 2019 Dec; 244():604-611. PubMed ID: 29397949
[TBL] [Abstract][Full Text] [Related]
12. The effect of combined risk factors on breast cancer-related lymphedema: a study using decision trees.
Jinbo K; Fujita T; Kasahara R; Jinbo R; Kisara S; Onobe J; Kimijima I; Yasuda M; Yamamoto Y
Breast Cancer; 2023 Jul; 30(4):685-688. PubMed ID: 36917351
[TBL] [Abstract][Full Text] [Related]
13. Breast Cancer-Related Lymphedema (BCRL) and Bioimpedance Spectroscopy: Long-Term Follow-Up, Surveillance Recommendations, and Multidisciplinary Risk Factors.
Jeffers EJ; Wagner JL; Korentager SS; Larson KE; Balanoff CR; Baker J; Chollet-Hinton L; Kilgore LJ
Ann Surg Oncol; 2023 Oct; 30(10):6258-6265. PubMed ID: 37535267
[TBL] [Abstract][Full Text] [Related]
14. A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement for the Prevention of Lymphedema Following Treatment for Breast Cancer: Interim Analysis.
Ridner SH; Dietrich MS; Cowher MS; Taback B; McLaughlin S; Ajkay N; Boyages J; Koelmeyer L; DeSnyder SM; Wagner J; Abramson V; Moore A; Shah C
Ann Surg Oncol; 2019 Oct; 26(10):3250-3259. PubMed ID: 31054038
[TBL] [Abstract][Full Text] [Related]
15. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
Zou L; Liu FH; Shen PP; Hu Y; Liu XQ; Xu YY; Pen QL; Wang B; Zhu YQ; Tian Y
Breast Cancer; 2018 May; 25(3):309-314. PubMed ID: 29397555
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the Risk Factors of Breast Cancer-Related Lymphedema and Construction and Evaluation of a Prediction Model.
Li H; Li WB; Sun ZX; Yu J; Lv PY; Li CX; Liang X; Yu Y; Zhao ZB
Lymphat Res Biol; 2023 Dec; 21(6):565-573. PubMed ID: 37768813
[No Abstract] [Full Text] [Related]
17. Quantifying the Impact of Axillary Surgery and Nodal Irradiation on Breast Cancer-Related Lymphedema and Local Tumor Control: Long-Term Results From a Prospective Screening Trial.
Naoum GE; Roberts S; Brunelle CL; Shui AM; Salama L; Daniell K; Gillespie T; Bucci L; Smith BL; Ho AY; Taghian AG
J Clin Oncol; 2020 Oct; 38(29):3430-3438. PubMed ID: 32730184
[TBL] [Abstract][Full Text] [Related]
18. Time trend of breast cancer-related lymphedema according to body mass index.
Ogiya A; Kimura K; Ueno T; Iwase T; Ohno S
Eur J Surg Oncol; 2024 Jun; 50(6):108350. PubMed ID: 38653160
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer-Related Lymphedema.
Montagna G; Zhang J; Sevilimedu V; Charyn J; Abbate K; Gomez EA; Mehrara B; Morrow M; Barrio AV
JAMA Oncol; 2022 Aug; 8(8):1195-1200. PubMed ID: 35679026
[TBL] [Abstract][Full Text] [Related]
20. The Axillary Lateral Vessel Thoracic Junction Is Not an Organ at Risk for Breast Cancer-Related Lymphedema.
Healy E; Beyer S; Jhawar S; White JR; Bazan JG
Int J Radiat Oncol Biol Phys; 2023 Oct; 117(2):452-460. PubMed ID: 37059233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
